Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
RecruitingNot a traditional drug phaseinterventionalRules rewrite
Not a traditional drug phase: Peanut Snack Experimental for Weight Loss
The aging population is rapidly increasing, and it is important to identify dietary factors that can prevent disease and promote health in this group. Legumes, such as peanuts, are a plant-based food high in protein and unsaturated fat making this a healthy choice but are not consumed frequently enough in older adults.
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are Peanut Snack Experimental, or Nut-free Snack. The registry lists allocation as randomized. The aging population is rapidly increasing, and it is important to identify dietary factors that can prevent disease and promote health in this group.
They plan to enroll about 44 people at New Brunswick. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Metabolic Health, Bones and Nuts Sources of Fatty Acids During Weight Loss in Adults
Primary outcome (registry wording): Bone Mineral Density (BMD - total hip)
Who it is for (from inclusion criteria)
Ages 50 Years to 75 Years
Men and postmenopausal women (\>2 years since last menses), ages 50-75 years
Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity
Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for 24 weeks
Must attend on-site visits (about 10) in New Brunswick, NJ, USA (transportation/reimbursement for travel not included)
Who the registry excludes
Peanut allergies or intolerances
Individuals with \>5% weight loss in the past 3 months or those with extreme dietary/physical activity habits
An inability to follow the experimental intervention or to perform the required specimen collections
Individuals with significant psychiatric or food disorders
Current diagnosis, or history of cancer in past 3 years
Current diagnosis or history of bone diseases, type I or II diabetes if using insulin, gastrointestinal disease, hyperparathyroidism, Alzheimer's disease, mild cognitive impairment, untreated thyroid disease, significant immune, hepatic, cardiac, or renal disease
The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute health information to support natural history studies, participant recruitment, and other research efforts.
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Nonalcoholic fatty liver disease is the most common liver disease in Western countries, due in large part to its association with type 2 diabetes and obesity. The more advanced form of this disease is known as nonalcoholic steatohepatitis (NASH).
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT06949280?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT06949280?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.